The Pancreatic Society of Great Britain & Ireland.


An alliance of professionals advancing the understanding and management of pancreatic conditions, for the benefit of patients.

(PERT) shortage

Position Statement: Pancreatic enzyme replacement therapy

Make a Donation to PSGBI

Help support our work

Grants and Bursaries

Funding for Member projects

Patients

Information for patients

Access the Journal

Free access for members

Our Mission:


The Pancreatic Society of Great Britain and Ireland will promote, encourage and support study and research into diseases of the pancreas and will actively promote professional discussions and dissemination of knowledge, for the benefit of patients and the public in the United Kingdom and Ireland. We will work to build professional relationships with other national societies throughout the world and support our members through shared learning from these relationships.

History: The first meeting of the Pancreatic Society of Great Britain and Ireland was held on 16 June 1975 at the Royal College of Surgeons of England.Sir Rodney Smith was elected as the first president of the Society and Mr Michael Knight as Secretary and Treasurer. Other officers elected at the meeting included Professor Henry Howat, Professor Patrick Collins, Mr Peter Bevan, Dr Martin Sarner and Mr John Trapnell.

The first presentation was given by Mr C W Imrie. At the first meeting there were sixty-eight participants. Since then the Society has held an annual meeting hosted by the President and regularly attended by over a hundred delegates.

The Pancreatic Society has close links with the British Society of Gastroenterology (BSG), the European Pancreatic Club (EPC) and the International Association of Pancreatology (IAP). The abstracts of the annual meeting of the Society are published in the journal “Pancreatology”.


 

 

News

There are no articles currently

Events

There are no upcoming events.

Pancreatology Journal, latest articles

Prediction of pancreatic cancer in patients with new onset hyperglycemia: A modified ENDPAC model

15 Sep 2024, 4 p.m.

Publication date: Available online 14 September 2024Source: PancreatologyAuthor(s): Wansu Chen, ...

Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.

14 Sep 2024, 1 p.m.

Publication date: Available online 13 September 2024Source: PancreatologyAuthor(s): Quoc Riccardo ...

Comparison between pancreatoblastoma (PB) and solid pseudopapillary neoplasm (SPN) in pediatric patients with enhanced CT

14 Sep 2024, 1 p.m.

Publication date: Available online 14 September 2024Source: PancreatologyAuthor(s): Lin Chen, ...

Efficiency evaluation of dual-energy CT to predict the postoperative early recurrence of pancreatic ductal adenocarcinoma

14 Sep 2024, 1 p.m.

Publication date: Available online 14 September 2024Source: PancreatologyAuthor(s): Si-Yao Yu, ...

Early selective enteral feeding in combination with active decompression of duodenum in treatment of moderate and severe acute pancreatitis – a proof-of-concept clinical study.

14 Sep 2024, 1 p.m.

Publication date: Available online 14 September 2024Source: PancreatologyAuthor(s): A.A. Kashintsev, ...

Increased kidney stone risk following total pancreatectomy with islet autotransplantation

12 Sep 2024, 1 p.m.

Publication date: Available online 12 September 2024Source: PancreatologyAuthor(s): Nandini Avula, ...

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA Damage Repair system variants.

12 Sep 2024, 1 p.m.

Publication date: Available online 12 September 2024Source: PancreatologyAuthor(s): Catia Carconi, ...

Reply to Moyer MT, et al. “Response to international evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas regarding EUS guided cyst chemoablation”.

12 Sep 2024, 1 p.m.

Publication date: Available online 12 September 2024Source: PancreatologyAuthor(s): Takao Ohtsuka, ...